Real-world study assessing Efficacy of TezepeLumaB in patients with severe asthma regardless of phenotype in Russia

Trial Identifier:	D5180R00029
Sponsor:	AstraZeneca
Start Date:	July 2024
Primary Completion Date:	June 2026
Study Completion Date:	June 2026

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

No locations posted.

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.